Santen Pharmaceutical Co., Ltd., the leader in ophthalmic drug development, has selected ArisGlobal to create a single global safety database and improve the efficiency and quality of their global safety vigilance processes. Santen Pharmaceutical's safety suite will include ArisGlobal's LifeSphere MultiVigilance (LSMV), LifeSphere Reporting and Analytics and LifeSphere Intake and Triage solutions to automate key safety vigilance activities, reduce costs, and increase compliance. "LSMV's advanced artificial intelligence (AI) and machine learning automates repetitive manual tasks, improving efficiency and compliance levels. Switching to LSMV makes our team dramatically more efficient," added Dr. Shimada, head of global safety vigilance at Santen Pharmaceutical. Santen joins more than 250 life science companies, including 9 regulatory authorities, who use ArisGlobal's safety, medical affairs, clinical and regulatory solutions, benefiting from rapid implementation on a multi-tenant cloud with upgrades delivered seamlessly.